These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 25769405)

  • 21. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.
    Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H
    Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
    You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
    Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice.
    Bagherpoor AJ; Shameem M; Luo X; Seelig D; Kassie F
    Carcinogenesis; 2023 Jun; 44(4):291-303. PubMed ID: 37053033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
    Cao HZ; Yang WT; Zheng PS
    BMC Cancer; 2022 May; 22(1):521. PubMed ID: 35534815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced Tumor-Specific Disulfiram Chemotherapy by
    Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
    J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
    Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfiram and Its Copper Chelate Attenuate Cisplatin-Induced Acute Nephrotoxicity in Rats Via Reduction of Oxidative Stress and Inflammation.
    Khairnar SI; Mahajan UB; Patil KR; Patel HM; Shinde SD; Goyal SN; Belemkar S; Ojha S; Patil CR
    Biol Trace Elem Res; 2020 Jan; 193(1):174-184. PubMed ID: 30825159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
    Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal microbiota regulates anti-tumor effect of disulfiram combined with Cu
    Hu H; Cui L; Lu J; Wei K; Wei J; Li S; Zou C; Chen T
    Cancer Med; 2020 Sep; 9(18):6791-6801. PubMed ID: 32750218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
    Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
    Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disulfiram: A novel repurposed drug for cancer therapy.
    Zeng M; Wu B; Wei W; Jiang Z; Li P; Quan Y; Hu X
    Chin Med J (Engl); 2024 Jun; 137(12):1389-1398. PubMed ID: 38275022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231.
    Chu M; An X; Fu C; Yu H; Zhang D; Li Q; Man X; Dai X; Li Z
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):186. PubMed ID: 37664913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint.
    Chu M; An X; Zhang D; Li Q; Dai X; Yu H; Li Z
    Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119169. PubMed ID: 34763028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.
    Chen D; Cui QC; Yang H; Dou QP
    Cancer Res; 2006 Nov; 66(21):10425-33. PubMed ID: 17079463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.
    Evans MK; Sauer SJ; Nath S; Robinson TJ; Morse MA; Devi GR
    Cell Death Dis; 2016 Jan; 7(1):e2073. PubMed ID: 26821068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells.
    Chen GS; Chen SY; Liu ST; Hsieh CC; Lee SP; Huang SM
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties.
    Yip NC; Fombon IS; Liu P; Brown S; Kannappan V; Armesilla AL; Xu B; Cassidy J; Darling JL; Wang W
    Br J Cancer; 2011 May; 104(10):1564-74. PubMed ID: 21487404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.